DrugPatentWatch Database Preview
Aizant Company Profile
» See Plans and Pricing
What is the competitive landscape for AIZANT, and what generic and branded alternatives to AIZANT drugs are available?
AIZANT has two approved drugs.
Summary for Aizant
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Aizant: | See patent lawsuits for Aizant |
Drugs and US Patents for Aizant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aizant | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 210948-002 | Mar 15, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
Aizant | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 210948-001 | Mar 15, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
Aizant | ZILEUTON | zileuton | TABLET, EXTENDED RELEASE;ORAL | 211390-001 | Oct 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.